The reason magic mushrooms make music more emotional revealed
Scientists have found that certain psychedelic ingredients found in ‘magic’ mushrooms have an impact on the area of our brain that is associated with our emotional response to music. According to Science Focus, in a study in which 20 participants listened to music before and after taking a controlled dose of psilocybin – a naturally […]
Boris Johnson approved the rescheduling of psilocybin – but the ‘Home Office fails to act’
A Conservative MP says the prime minister approved the rescheduling of psilocybin months ago, but the Home Office has yet to act as it was instructed. According to the Daily Express, the Chairman of the Conservative Drug Policy Reform Group (CDPRG), Crispin Blunt MP, has urged Boris Johnson to reschedule the drug psilocybin – a […]
British start-up to help deliver innovative psychedelics to patients
A partnership between two innovative start-ups leads the way for advancing patient access to psychedelic medicines in Europe. According to a statement released today, Copenhagen-based Octarine Bio, has partnered with clinical research organisation Clerkenwell Health to deliver clinical trials. Octarine Bio is a synthetic biology drug development company that produces psilocybin from sugar using fermentation. […]
World’s very first research institute for psychedelic therapies set to open
A global team of researchers have launched a first-of-its-kind research institute that will develop psychedelic medicines designed for the treatment of a number of mental health disorders and other medical conditions. According to a statement, the network is headquartered in Melbourne, Australia, and is supported with a planned investment of at least AUS $40 million […]
New partnership formed to create psilocybin patch for mental health conditions
A noted psychedelic medicine start-up has announced plans to develop a transdermal patch for sustained delivery of psilocybin, the active ingredient in ‘magic’ mushrooms, for mental health applications. According to a joint statement issued by Ei.Ventures and Tioga Research, the target is to apply the therapeutic potential of psychedelics to help the millions of people […]
UK company to develop psychedelic medicines for patients with depression and headaches
A UK-based company has raised money for the development of medicines with low-dose psilocybin to treat patients with rare headaches and a severe type of depression. Beckley Psytech, of Oxford, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, has announced that it secured £58m to fund […]
Study finds psilocybin repairs brain cell damage associated with depression
A new study conducted by Yale University has found that the psychedelic compound psilocybin – a naturally occurring chemical produced by ‘magic mushrooms’ – can repair brain cells damaged by depression. The compound was seen to prompt an immediate and long-lasting increase in connections between neurons. According to Yale researchers, the administration of a single […]
The new wave of research into the therapeutic potential of psychedelics
Experts in the medical field and members of the public are increasingly beginning to pay attention to the medicinal and therapeutic potential of psychedelic substances such as LSD, psilocybin, and DMT. In fact, research into the potential uses of psychedelics is at an all-time high as the demand for alternative treatment options increases. A small […]
New poll shows widespread support for psilocybin research among the British public
The first national poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes has revealed that the British public support reform of psilocybin policy and a decision to reschedule it. In a new YouGov poll, commissioned by Drug Science, researchers found that a majority in every individual demographic, political, or regional population […]
The Potential of Psychedelic Medical Treatment in the UK
Psychedelic drugs such as MDMA, ketamine, DMT, and magic mushrooms often conjure up stereotypical images of party-goers and ‘hippies’, yet increasing evidence is supporting the use of these drugs in therapeutic medicine. As the medical and public perception of these substances continues to evolve, what is the potential for psychedelic medical treatment in the UK? […]